Demystify the technology challenges associated with translational research.
A paradigm shift is emerging in the pharmaceutical industry that will change drug discovery and development. The pace of this shift towards translational medicine will largely depend on technology vendors and their ability to offer solutions that address both the cultural and technology issues surrounding translational research. This brief will argue the following:
Translational medicine is real and fueled by patient-centered care;
Existing business models are called into question, driving translational medicine; and
Both cultural and technology barriers slow the progress of translational medicine.
This white paper is written by Datamonitor, Sponsored by InforSense.
Offered Free by: InforSense See All Resources from: InforSense